| scholarly article | Q13442814 |
| editorial | Q871232 |
| P50 | author | David R Bangsberg | Q60227555 |
| Lynn T Matthews | Q89133756 | ||
| Jared M Baeten | Q89443633 | ||
| Connie Celum | Q42571941 | ||
| P2860 | cites work | Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial | Q21144715 |
| Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies | Q22252604 | ||
| Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals | Q24241184 | ||
| Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure | Q24243119 | ||
| Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection | Q28469067 | ||
| Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial | Q28469218 | ||
| Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir | Q28472146 | ||
| Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel | Q28473376 | ||
| HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness | Q28474086 | ||
| Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial | Q29619176 | ||
| Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial | Q29619179 | ||
| New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data | Q31160798 | ||
| Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study | Q31954225 | ||
| Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe | Q33280138 | ||
| Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings | Q33299456 | ||
| Promotion of couples' voluntary counselling and testing for HIV through influential networks in two African capital cities | Q33309750 | ||
| The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study. | Q33332191 | ||
| Effect of early versus deferred antiretroviral therapy for HIV on survival | Q33789114 | ||
| Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe | Q33833876 | ||
| Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial | Q34721145 | ||
| K65R, TAMs and tenofovir. | Q35787578 | ||
| Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa | Q35821445 | ||
| Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. | Q46937577 | ||
| High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner--two challenging issues. | Q48026509 | ||
| HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial | Q48490664 | ||
| Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. | Q51740512 | ||
| The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis | Q57586547 | ||
| Adherence is not a barrier to successful antiretroviral therapy in South Africa | Q58042164 | ||
| Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma | Q59151109 | ||
| Sexual behavior of HIV discordant couples after HIV counseling and testing | Q73149539 | ||
| Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group | Q74237000 | ||
| Strategies for harm reduction among HIV-affected couples who want to conceive | Q83612307 | ||
| Resistance issues with new nucleoside/nucleotide backbone options | Q35866784 | ||
| Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis | Q36560027 | ||
| The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa | Q36619827 | ||
| Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda | Q36712404 | ||
| Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial | Q36740882 | ||
| Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. | Q36793483 | ||
| Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects. | Q36870864 | ||
| HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy | Q36879257 | ||
| Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing | Q36916579 | ||
| Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis | Q37452644 | ||
| Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial | Q37867045 | ||
| Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. | Q37870046 | ||
| Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group | Q37878983 | ||
| A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda | Q37880530 | ||
| Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda | Q38881073 | ||
| Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials | Q38881398 | ||
| Incidence of HIV infection in stable sexual partnerships: a retrospective cohort study of 1802 couples in Mwanza Region, Tanzania | Q39085904 | ||
| Primary and secondary infertility in sub-Saharan Africa | Q39161244 | ||
| Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania | Q39501645 | ||
| 'Men leave me as I cannot have children': women's experiences with involuntary childlessness | Q39604280 | ||
| Psychological distress among women suffering from couple infertility in South Africa: a quantitative assessment | Q39710989 | ||
| The unintended consequences of intended pregnancies: youth, condom use, and HIV transmission in Mozambique | Q40019469 | ||
| Changes in sexual risk behavior among participants in a prep hiv prevention trial | Q40022222 | ||
| Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study | Q40115633 | ||
| Prevalence and determinants of fertility intentions of HIV-infected women and men receiving antiretroviral therapy in South Africa | Q40219362 | ||
| Reproductive choice in men and women living with HIV: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA Study). | Q40261773 | ||
| Fertility desires and intentions of HIV-positive men and women | Q40692533 | ||
| Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy. | Q43417954 | ||
| Preexposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child | Q43449821 | ||
| Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). | Q43901906 | ||
| The structure and outcomes of a HIV postexposure prophylaxis program in a high HIV prevalence setup in western Kenya | Q44127207 | ||
| Natural conception in HIV-negative women with HIV-infected partners | Q44810591 | ||
| Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand | Q44838476 | ||
| The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study | Q44968108 | ||
| Human immunodeficiency virus infection and fertility care in the United Kingdom: demand and supply | Q45418099 | ||
| Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe | Q46080805 | ||
| Adverse effects of tenofovir use in HIV-infected pregnant women and their infants | Q46288817 | ||
| Pregnancy and HIV transmission among HIV-discordant couples in a clinical trial in Kisumu, Kenya | Q46312859 | ||
| Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 | ||
| Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center | Q46822291 | ||
| Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial | Q46871110 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| HIV transmission | Q49029021 | ||
| P304 | page(s) | 1975-1982 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Periconception pre-exposure prophylaxis to prevent HIV transmission: benefits, risks, and challenges to implementation | |
| P478 | volume | 24 |
| Q60914108 | A Systematic Review of the Current Status of Safer Conception Strategies for HIV Affected Heterosexual Couples in Sub-Saharan Africa |
| Q36717408 | A conceptual framework for understanding HIV risk behavior in the context of supporting fertility goals among HIV-serodiscordant couples |
| Q34459002 | Achieving pregnancy safely: perspectives on timed vaginal insemination among HIV-serodiscordant couples and health-care providers in Kisumu, Kenya |
| Q28270788 | Antiretroviral prophylaxis for HIV prevention in heterosexual men and women |
| Q36964167 | Antiretrovirals and safer conception for HIV-serodiscordant couples |
| Q43931427 | Application of an ecological framework to examine barriers to the adoption of safer conception strategies by HIV-affected couples |
| Q37017876 | Awareness of and willingness to use oral pre-exposure prophylaxis for HIV prevention among HIV-serodiscordant heterosexual couples: a cross-sectional survey in Xinjiang, China |
| Q36208647 | Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners |
| Q37641162 | Challenges with couples, serodiscordance and HIV disclosure: healthcare provider perspectives on delivering safer conception services for HIV-affected couples, South Africa |
| Q40458898 | Childbearing Experiences Following an HIV Diagnosis in Iringa, Tanzania. |
| Q35780443 | Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm |
| Q40265835 | Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples |
| Q47549479 | Difficult decisions: Evaluating individual and couple-level fertility intentions and HIV acquisition among HIV serodiscordant couples in Zambia. |
| Q64058666 | Empowering HIV-infected women in low-resource settings: A pilot study evaluating a patient-centered HIV prevention strategy for reproduction in Kisumu, Kenya |
| Q26829472 | Engaging HIV care providers in conversations with their reproductive-age patients about fertility desires and intentions: a historical review of the HIV epidemic in the United States |
| Q36178220 | Evaluating safer conception options for HIV-serodiscordant couples (HIV-infected female/HIV-uninfected male): a closer look at vaginal insemination |
| Q36006803 | Fertility Decision-Making Among Kenyan HIV-Serodiscordant Couples Who Recently Conceived: Implications for Safer Conception Planning |
| Q38865413 | Fertility care interventions should be provided as the first line options for HIV+ serodiscordant couples who desire children in settings with affordable access to care, regardless of their fertility status |
| Q26996011 | HIV-1 prevention for HIV-1 serodiscordant couples |
| Q34110847 | High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis |
| Q38062206 | How the global call for elimination of pediatric HIV can support HIV-positive women to achieve their pregnancy intentions |
| Q35214337 | Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples |
| Q33864578 | My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya |
| Q35153213 | Nanoparticle incorporation of melittin reduces sperm and vaginal epithelium cytotoxicity |
| Q36409225 | Oral antiretroviral chemoprophylaxis: current status |
| Q27023352 | Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges |
| Q38774163 | People living with HIV and procreation: 30 years of progress from prohibition to freedom? |
| Q64941484 | Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya. |
| Q37050396 | Periconception HIV Risk Behavior Among Men and Women Reporting HIV-Serodiscordant Partners in KwaZulu-Natal, South Africa |
| Q37088565 | Perspectives of healthcare providers and HIV-affected individuals and couples during the development of a Safer Conception Counseling Toolkit in Kenya: stigma, fears, and recommendations for the delivery of services |
| Q34606593 | Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis |
| Q43241737 | PrEP Implementation Science: State-of-the-Art and Research Agenda |
| Q40496392 | PrEP Whores and HIV Prevention: The Queer Communication of HIV Pre-Exposure Prophylaxis (PrEP). |
| Q37352576 | PrEP implementation research in Africa: what is new? |
| Q34436959 | Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men |
| Q35875719 | Pre-exposure prophylaxis in Southern Africa: feasible or not? |
| Q26828937 | Preconception care: delivery strategies and packages for care |
| Q26996391 | Preconception care: preventing and treating infections |
| Q26825042 | Preexposure prophylaxis for HIV prevention: where have we been and where are we going? |
| Q36853885 | Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure? |
| Q35184560 | Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial |
| Q92213693 | Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa |
| Q38126891 | Reproductive and maternal healthcare needs of HIV infected women |
| Q36184685 | Reproductive counseling by clinic healthcare workers in Durban, South Africa: perspectives from HIV-infected men and women reporting serodiscordant partners |
| Q36578074 | Reproductive decision-making and periconception practices among HIV-positive men and women attending HIV services in Durban, South Africa |
| Q35771501 | Reproductive health options among HIV-infected persons in the low-income Niger Delta of Nigeria |
| Q36163886 | Risk Factor Associated with Negative Spouse HIV Seroconversion among Sero-Different Couples: A Nested Case-Control Retrospective Survey Study in 30 Counties in Rural China |
| Q37966666 | Safer conception interventions for HIV-affected couples: implications for resource-constrained settings. |
| Q53703278 | Stigma gets in my way: Factors affecting client-provider communication regarding childbearing among people living with HIV in Uganda. |
| Q37061624 | Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis |
| Q35317678 | The HIV epidemic and sexual and reproductive health policy integration: views of South African policymakers. |
| Q28487926 | The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies |
| Q35906897 | The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women |
| Q38062207 | The pregnancy decisions of HIV-positive women: the state of knowledge and way forward |
| Q33769798 | The role of family planning in achieving safe pregnancy for serodiscordant couples: commentary from the United States government's interagency task force on family planning and HIV service integration |
| Q57902608 | Turning the Tide Against HIV |
| Q36816377 | Use of antiretrovirals for HIV prevention: what do we know and what don't we know? |
| Q34614273 | Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial |
Search more.